Administration in Efficacy of Melatonin Reducing Headaches in Children With Migraines and Sleep Disorders: A

Afshin Fayyazi1, Abasali Abdollahi2, Ali Moradi2

  • 1Department of Pediatric Neurology, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.

Insights

Melatonin combined with propranolol significantly reduced daily migraine headaches in children with sleep disorders. This combination therapy proved more effective than propranolol alone for migraine symptom relief.

Area of Science:

  • Pediatric Neurology
  • Sleep Medicine
  • Clinical Pharmacology

Background:

  • Migraine headaches are common in children, often exacerbated by sleep disorders.
  • Melatonin is a potential prophylactic agent for pediatric migraines.

Purpose of the Study:

  • To assess the efficacy of melatonin in managing migraine symptoms in children with co-occurring sleep disorders.
  • To compare the effectiveness of melatonin plus propranolol versus propranolol alone in pediatric migraine treatment.

Main Methods:

  • A randomized clinical trial involving 30 children (5-15 years) with migraine and sleep disorders.
  • Intervention group received melatonin (3 mg/day) + propranolol (1 mg/kg/day); control group received propranolol alone.
  • Migraine severity assessed by PEDMIDAS and Likert scale; sleep disorders evaluated using the Children's Sleep Habits Questionnaire (CSHQ).

Main Results:

  • The group receiving melatonin and propranolol showed a significant reduction in daily headaches at one and four months post-treatment (P=0.02, P=0.03).
  • No significant difference in sleep quality was observed between the melatonin and control groups.
  • The study included 30 children, with 9 girls and 21 boys.

Conclusions:

  • Combination therapy with melatonin and propranolol is more effective in alleviating migraine headaches in children than propranolol monotherapy.
  • Melatonin may be a valuable adjunct treatment for pediatric migraine, particularly in those with sleep disturbances.
Abstract

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
306
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
224
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
568
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
104